Correlation Between RIV Capital and Bionoid Pharma
Can any of the company-specific risk be diversified away by investing in both RIV Capital and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RIV Capital and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RIV Capital and Bionoid Pharma, you can compare the effects of market volatilities on RIV Capital and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RIV Capital with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of RIV Capital and Bionoid Pharma.
Diversification Opportunities for RIV Capital and Bionoid Pharma
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between RIV and Bionoid is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding RIV Capital and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and RIV Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RIV Capital are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of RIV Capital i.e., RIV Capital and Bionoid Pharma go up and down completely randomly.
Pair Corralation between RIV Capital and Bionoid Pharma
Assuming the 90 days horizon RIV Capital is expected to under-perform the Bionoid Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, RIV Capital is 2.02 times less risky than Bionoid Pharma. The pink sheet trades about 0.0 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 25.00 in Bionoid Pharma on August 29, 2024 and sell it today you would lose (14.00) from holding Bionoid Pharma or give up 56.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RIV Capital vs. Bionoid Pharma
Performance |
| Timeline |
| RIV Capital |
| Bionoid Pharma |
RIV Capital and Bionoid Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RIV Capital and Bionoid Pharma
The main advantage of trading using opposite RIV Capital and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RIV Capital position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.| RIV Capital vs. Green Cures Botanical | RIV Capital vs. Cann American Corp | RIV Capital vs. Rimrock Gold Corp | RIV Capital vs. Galexxy Holdings |
| Bionoid Pharma vs. Braskem SA Class | Bionoid Pharma vs. GMS Inc | Bionoid Pharma vs. Air Products and | Bionoid Pharma vs. National Vision Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |